See more : The Ruby Mills Limited (RUBYMILLS.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Pharma-Bio Serv, Inc. (PBSV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Pharma-Bio Serv, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
You may be interested
- Marin Software Incorporated (MRIN) Income Statement Analysis – Financial Results
- Union Pacific Corporation (0R2E.L) Income Statement Analysis – Financial Results
- Trustco Group Holdings Limited (TSCHY) Income Statement Analysis – Financial Results
- Hingham Institution for Savings (HIFS) Income Statement Analysis – Financial Results
- NSTAR Electric Company (NSARO) Income Statement Analysis – Financial Results
Pharma-Bio Serv, Inc. (PBSV)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.pharmabioserv.com
About Pharma-Bio Serv, Inc.
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products companies in Puerto Rico, the United States, Europe, and Brazil. Its technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16.98M | 19.40M | 20.12M | 21.56M | 19.51M | 17.80M | 15.58M | 19.54M | 23.38M | 27.56M | 33.06M | 29.23M | 19.93M | 11.35M | 11.48M | 15.20M | 16.20M | 14.23M | 10.00K |
| Cost of Revenue | 11.91M | 14.52M | 14.76M | 14.90M | 13.33M | 12.11M | 11.97M | 13.75M | 15.90M | 18.58M | 21.23M | 19.36M | 13.07M | 7.95M | 7.64M | 9.41M | 9.38M | 8.12M | 0.00 |
| Gross Profit | 5.07M | 4.88M | 5.36M | 6.67M | 6.18M | 5.69M | 3.61M | 5.78M | 7.48M | 8.97M | 11.83M | 9.87M | 6.86M | 3.39M | 3.84M | 5.79M | 6.82M | 6.11M | 10.00K |
| Gross Profit Ratio | 29.84% | 25.16% | 26.65% | 30.92% | 31.66% | 31.95% | 23.18% | 29.60% | 32.01% | 32.56% | 35.79% | 33.78% | 34.42% | 29.90% | 33.44% | 38.10% | 42.11% | 42.96% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.60M | 5.04M | 5.87M | 5.70M | 6.11M | 5.76M | 4.14M | 3.41M | 2.78M | 2.92M | 3.14M | 3.18M | 2.03M | 40.00K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.95M | 3.71M | 9.21M | 4.44M | 4.48M | 4.60M | 5.04M | 5.87M | 5.70M | 6.11M | 5.76M | 4.14M | 3.41M | 2.78M | 2.92M | 3.14M | 3.18M | 2.03M | 40.00K |
| Other Expenses | 0.00 | 13.42K | 1.98M | 64.46K | 526.57K | 435.53K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 194.98K | 0.00 |
| Operating Expenses | 3.95M | 3.71M | 9.21M | 4.44M | 4.48M | 4.60M | 5.04M | 5.87M | 5.70M | 6.11M | 5.76M | 4.14M | 3.41M | 2.78M | 2.92M | 3.14M | 3.18M | 2.23M | 40.00K |
| Cost & Expenses | 15.86M | 18.22M | 23.97M | 19.34M | 17.81M | 16.71M | 17.00M | 19.63M | 21.60M | 24.69M | 26.99M | 23.49M | 16.48M | 10.74M | 10.56M | 12.54M | 12.56M | 10.34M | 40.00K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 18.81K | 5.35K | 10.33K | 11.08K | 19.71K | 14.98K | 26.96K | 82.71M | 107.51M | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 223.96K | 7.34K | 7.19K | 7.21K | 7.43K | 6.61K | 5.61K | 52.39K | 144.74K | 335.99K | 392.74K | 0.00 |
| Depreciation & Amortization | 194.32K | 51.11K | 72.73K | 86.28K | 99.10K | 74.60K | 107.68K | 312.56K | 357.46K | 377.20K | 344.52K | 321.73K | 320.86K | 321.71K | 307.33K | 227.15K | 208.23K | 194.98K | 0.00 |
| EBITDA | 1.31M | 1.23M | -3.78M | 2.31M | 1.80M | 1.16M | -710.02K | 220.80K | 2.16M | 3.24M | 6.42M | 6.08M | 3.79M | 948.51K | 1.26M | 2.96M | 3.86M | 4.08M | -20.00K |
| EBITDA Ratio | 7.73% | 6.32% | -18.80% | 10.72% | 9.21% | 6.53% | -6.39% | 1.70% | 9.23% | 11.78% | 19.44% | 20.76% | 19.03% | 8.34% | 10.89% | 18.96% | 23.95% | 28.69% | -200.00% |
| Operating Income | 1.12M | 1.17M | -3.85M | 2.23M | 1.70M | 1.09M | -1.43M | -91.76K | 1.78M | 2.86M | 6.07M | 5.73M | 3.45M | 609.89K | 915.46K | 2.65M | 3.65M | 3.89M | -20.00K |
| Operating Income Ratio | 6.58% | 6.06% | -19.16% | 10.32% | 8.70% | 6.11% | -9.15% | -0.47% | 7.62% | 10.39% | 18.36% | 19.62% | 17.32% | 5.38% | 7.97% | 17.46% | 22.51% | 27.32% | -200.00% |
| Total Other Income/Expenses | 570.08K | 13.42K | 1.98M | 64.46K | 526.57K | 435.53K | 43.75K | -111.98K | 11.46K | 14.02K | 4.60K | 22.00K | 11.78K | 11.30K | -19.35K | -144.74K | -310.33K | -392.74K | 0.00 |
| Income Before Tax | 1.69M | 1.19M | -1.88M | 2.29M | 2.22M | 1.52M | -1.41M | -203.74K | 1.79M | 2.88M | 6.08M | 5.76M | 3.46M | 621.19K | 896.10K | 2.51M | 3.34M | 3.50M | -20.00K |
| Income Before Tax Ratio | 9.94% | 6.13% | -9.33% | 10.62% | 11.40% | 8.56% | -9.06% | -1.04% | 7.67% | 10.45% | 18.38% | 19.69% | 17.38% | 5.47% | 7.81% | 16.51% | 20.60% | 24.56% | -200.00% |
| Income Tax Expense | 377.31K | 181.68K | 213.25K | 239.09K | 135.99K | 2.79M | 3.87K | 52.83K | 167.98K | 464.53K | 1.17M | 1.07M | 304.80K | 249.28K | 361.35K | 1.02M | 1.44M | 1.16M | 0.00 |
| Net Income | 1.31M | 1.01M | -2.09M | 2.05M | 2.09M | 1.28M | -1.41M | -256.58K | 1.62M | 2.41M | 4.91M | 4.69M | 3.16M | 371.91K | 534.76K | 1.49M | 1.90M | 2.34M | -20.00K |
| Net Income Ratio | 7.72% | 5.19% | -10.39% | 9.51% | 10.70% | 7.19% | -9.08% | -1.31% | 6.95% | 8.76% | 14.84% | 16.04% | 15.85% | 3.28% | 4.66% | 9.79% | 11.73% | 16.41% | -200.00% |
| EPS | 0.06 | 0.04 | -0.09 | 0.09 | 0.09 | 0.06 | -0.06 | -0.01 | 0.07 | 0.11 | 0.22 | 0.23 | 0.15 | 0.02 | 0.03 | 0.07 | 0.10 | 0.22 | -0.07 |
| EPS Diluted | 0.06 | 0.04 | -0.09 | 0.09 | 0.09 | 0.06 | -0.06 | -0.01 | 0.07 | 0.10 | 0.21 | 0.20 | 0.14 | 0.02 | 0.02 | 0.07 | 0.09 | 0.13 | -0.07 |
| Weighted Avg Shares Out | 22.97M | 23.00M | 23.03M | 23.00M | 23.05M | 23.08M | 23.10M | 23.02M | 23.07M | 22.98M | 22.20M | 20.76M | 20.75M | 20.75M | 20.75M | 19.97M | 19.39M | 10.51M | 270.00K |
| Weighted Avg Shares Out (Dil) | 23.00M | 23.03M | 23.03M | 23.04M | 23.11M | 23.10M | 23.10M | 23.19M | 23.40M | 23.69M | 23.66M | 22.94M | 22.55M | 22.38M | 22.32M | 22.26M | 22.17M | 17.88M | 270.00K |
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2024
DORADO, PUERTO RICO / ACCESSWIRE / September 16, 2024 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic,...
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2024
DORADO, PUERTO RICO / ACCESSWIRE / June 14, 2024 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic,...
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2024
DORADO, PUERTO RICO / ACCESSWIRE / March 18, 2024 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic,...
Pharma-Bio Serv Announces Full Year Results
DORADO, PUERTO RICO / ACCESSWIRE / January 29, 2024 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical...
Pharma-Bio Serv Announces Special Dividend
DORADO, PUERTO RICO / ACCESSWIRE / December 21, 2023 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic,...
Pharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2023
DORADO, PUERTO RICO / ACCESSWIRE / September 14, 2023 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic,...
7 Best Penny Stocks Under $1 to Buy in July
While the market offers myriad avenues for high-risk speculation, the best penny stocks under $1 may present some of the most sweat-inducing, blood-pressure-racing moments ever. Yeah, sure, they're priced below a buck – what can go wrong?
7 Best Penny Stocks Under $1 to Buy Now
Anyone looking for the best penny stocks under $1 to buy likely knows how much risk this kind of speculation entails. However, it bears repeating: The ideas presented below carry incredible risk and volatility.
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2021
DORADO, PUERTO RICO / ACCESSWIRE / September 14, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory, compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device, cosmetic,...
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2021
Announces Regulatory and Compliance Advisory Board DORADO, PUERTO RICO / ACCESSWIRE / June 14, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the...
Source: https://incomestatements.info
Category: Stock Reports